Marshall Wace
ORIC icon

Marshall Wace’s Oric Pharmaceuticals ORIC Stock Holding History

Marshall Wace’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-47,695
Closed -$266K – 3037
2025
Q1 		$266K Buy
+47,695
New +$417K ﹤0.01% 2308
2023
Q2 		– Sell
-67,206
Closed -$383K – 2834
2023
Q1 		$383K Buy
+67,206
New +$351K ﹤0.01% 2211
2022
Q3 		– Sell
-124,067
Closed -$556K – 3681
2022
Q2 		$556K Buy
124,067
+111,420
+881% +$445K ﹤0.01% 2742
2022
Q1 		$67K Buy
+12,647
New +$114K ﹤0.01% 3229

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Marshall Wace's ORIC Position: Q2 2025 in Review

Marshall Wace sold out of Oric Pharmaceuticals (ORIC) in Q2 2025, closing a stake of 47,695 shares — an estimated $266K sold.

Marshall Wace first reported a position in ORIC in Q1 2022 and held it in 4 quarters. The position peaked at $556K in Q2 2022. 142 funds tracked by Wall St. Rank hold ORIC as of Q2 2025.

  • Marshall Wace reported no remaining Oric Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Marshall Wace sold 47,695 Oric Pharmaceuticals shares in Q2 2025, an estimated $266K.
  • Marshall Wace first reported a position in Oric Pharmaceuticals in Q1 2022 and held it in 4 quarters.
  • Marshall Wace's Oric Pharmaceuticals position peaked at $556K in Q2 2022.
  • 142 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.